Leadership, Planning, and Evaluation

摘要、领导力、规划和评估 印第安纳大学梅尔文和布伦·西蒙癌症中心(IUSCC)为 领导力、规划和评估，接受其高级领导人、计划负责人和 成员以及内部和外部咨询委员会。根据这一投入，IUSCC领导层 制定了战略计划，实施了这一计划，并定期评估其对其四项研究的影响 计划和多个共享资源(核心)推进我们为印第安纳州和 更远一点。2018年更新的IUSCC战略计划有四大研究支柱：生物学到 床边翻译研究、精准医学、人口健康(重点是预防，早期 检测和医疗保健差异)、生存和症状科学。遵循这一战略规划 在我们顾问的反馈下，高级领导层在过去的几年里实施了一些行动 资助期包括：1)解散乳腺癌计划，并将其成员合并到剩余的 基础和翻译研究项目；2)任命翻译研究副院长；3) 在癌症预防控制和试验发展中建立新的领导班子 治疗(EDT)计划；4)重新命名造血学、血液恶性肿瘤和免疫学(HMI) 血液病和恶性血液病(HHM)计划，强调其重点是“液体肿瘤”和 认识到癌症免疫学贯穿所有项目；5)创建社区外联办公室 并参与推动我们在全州的活动；6)正式建立肿瘤微环境 和转移(TMM)和HHM计划作为基础研究计划；7)开发新的癌症 生物信息学和翻译研究核心；以及8)整合IUSM的蛋白质组学和基因组学核心 与IUSCC合作。这些变化，在我们战略计划的主题支柱的推动下，推动了IUSCC的使命 通过支持团队科学、放大 社区外展和参与活动，并扩大我们的教育足迹，以激励下一个 一代癌症研究人员。

ABSTRACT, Leadership, Planning and Evaluation The Indiana University Melvin and Bren Simon Cancer Center (IUSCC) has established an effective process for Leadership, Planning and Evaluation that receives input from its Senior Leaders, Program Leaders and Membership as well as internal and external advisory committees. Based on this input, the IUSCC leadership has molded its strategic plan, implemented this plan, and regularly evaluates its impact on its four Research Programs and multiple Shared Resources (Cores) advancing our mission to serve the citizens of Indiana and beyond. The IUSCC Strategic Plan, which was updated in 2018, has four major research pillars: Biology to Bedside Translational Research, Precision Medicine , Population Health (with an emphasis on Prevention, Early Detection and Health Care Disparities), and Survivorship and Symptom Science. Following this strategic plan and with feedback from our advisors, the Senior Leadership implemented a number of actions during the last funding period including: 1) dissolving the Breast Cancer Program and integrated its members into the remaining basic and translational research programs; 2) appointing an Associate Dean of Translational Research; 3) installing new leadership in the Cancer Prevention and Control (CPC) and the Experimental and Developmental Therapeutics (EDT) Programs; 4) renaming Hematopoiesis, Hematologic Malignancies and Immunology (HMI) Program to Hematopoiesis and Hematologic Malignancies (HHM) to emphasize its focus on “liquid tumors” and recognizing that cancer immunology cuts across all programs; 5) creating the Office of Community Outreach and Engagement to drive our activities throughout the state; 6) formally establishing the Tumor Microenvironment and Metastasis (TMM) and HHM programs as basic research programs; 7) developed new Cancer Bioinformatics and Translational Research cores; and 8) integrated the IUSM's Proteomics and Genomics Cores with the IUSCC. These changes, informed by the thematic pillars of our strategic plan, drive the IUSCC's mission to impact research, patient care and education both locally and globally by bolstering team science, amplifying community outreach and engagement activities and expanding our educational footprint to inspire the next generation of cancer researchers.